Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: The Mayo Clinic experience (2004–2007)

[1]  R. Jacobson,et al.  Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. , 2006, Molecular genetics and metabolism.

[2]  Hugo Moser,et al.  Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.

[3]  S. Waisbren,et al.  Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result , 2006, Pediatrics.

[4]  G. Mitchell,et al.  Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. , 2006, Molecular genetics and metabolism.

[5]  E. Mayatepek,et al.  Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone. , 2006, Clinical chemistry.

[6]  P. Rinaldo,et al.  Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. , 2006, Mental retardation and developmental disabilities research reviews.

[7]  Edward R B McCabe,et al.  Two-tiered universal newborn screening strategy for severe combined immunodeficiency. , 2005, Molecular genetics and metabolism.

[8]  M. Poe,et al.  Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. , 2005, The New England journal of medicine.

[9]  O. Al-Dirbashi,et al.  Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia. , 2005, Analytical biochemistry.

[10]  J. Puck,et al.  Development of population-based newborn screening for severe combined immunodeficiency. , 2005, The Journal of allergy and clinical immunology.

[11]  N. Green,et al.  Neonatal screening by DNA microarray: spots and chips , 2005, Nature Reviews Genetics.

[12]  S. Edland,et al.  A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. , 2004, American journal of human genetics.

[13]  T. Zytkovicz,et al.  Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. , 2004, Clinical biochemistry.

[14]  M. Gelb,et al.  Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. , 2004, Clinical chemistry.

[15]  D. Chace,et al.  Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  N. Holtzman.  Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. , 2004, The Journal of pediatrics.

[17]  B. Casetta,et al.  Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. , 2004, Clinical chemistry.

[18]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[19]  N. Chamoles,et al.  Diagnosis of isovaleric acidaemia by tandem mass spectrometry: False positive result due to pivaloylcarnitine in a newborn screening programme , 1998, Journal of Inherited Metabolic Disease.

[20]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[21]  B. Andresen,et al.  Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. , 2003, Pediatrics.

[22]  J. Mallolas,et al.  Pilot study for the neonatal screening of fragile X syndrome , 2002, Prenatal diagnosis.

[23]  D. Chace,et al.  Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. , 2001, Clinical chemistry.

[24]  D. Frommhold,et al.  Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I. , 2001, Clinical chemistry.

[25]  J. R. Simmons,et al.  Reduction of false negative results in screening of newborns for homocystinuria. , 1999, The New England journal of medicine.

[26]  L. Middleton,et al.  Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. , 1998, Genetic testing.

[27]  G. Ellis,et al.  Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. , 1992, Clinical chemistry.

[28]  H. Zellweger,et al.  Newborn screening for Duchenne muscular dystrophy. , 1975, Pediatrics.